Clinical Trial

Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors

Name: Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors — clinical trial record (NCT07401316)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study will evaluate the utility of ctDNA detection in patients with high-risk stage I, stage II, and stage III germ cell tumor disease to develop a tool for post-treatment cancer cell detection.

Protocol Amendment History 2 changes

critical Recruitment opened 2026-05-05

notable Primary completion pushed: 2032-09 -> 2032-12 2026-05-05

Trial Details

NCT Number	NCT07401316
Lead Sponsor	Indiana University Collaborators: Natera, Inc.
Conditions	Germ Cell Cancer Metastatic
Enrollment	130 participants
Start Date	2026-06-03
Primary Completion	2032-12 (estimated)
Study Completion	2032-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-15